Find Grants

Search results

• Prot #C4591015: A Phase 2/3, Placebo-Controlled, Randomized, Observer-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of A SARS-COV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Olde

  Miller, E. S.

  Pfizer Inc.

  4/6/21 → 4/6/24

  Project: Research project

• Prot #DS3201-A-J101: A Phase 1 Multiple Ascending Dose Study of DS-3201b in Subjects with Lymphomas

  Pro, B.

  Daiichi Sankyo, Inc.

  4/7/21 → 4/7/24

  Project: Research project

• Prot #C-500-01: A Phase 1/2, Open-Label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of an Anti–CTLA-4 Human Monoclonal Antibody (AGEN1884) in Subjects with Advanced or Refractory Cancer and in Subjects who have Progre

  Kalyan, A.

  Agenus Inc.

  4/7/16 → 4/7/24

  Project: Research project

• Prot #U31402-A-U201: HERTHENA-Lung01: A Phase 2 Randomized Open-Label Study of Patritumab Deruxtecan (U3-1402) in Subjects with Previously Treated Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer (NSCLC)

  Patel, J. D.

  INC Research, LLC, Daiichi Sankyo, Inc.

  4/9/21 → 4/9/24

  Project: Research project

• Prot #U2-VEN-109: Phase I/II Study of Venetoclax in Combination with Ublituximab and Umbralisib (TGR-1202) in Patients with Relapsed or Refractory CLL/SLL

  Ma, S.

  TG Therapeutics, Inc.

  4/12/19 → 4/12/24

  Project: Research project

• Prot #BMT CTN 1506/2215-CL-0304: A Multi-Center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients with FLT3/ITD AML

  Frankfurt, O.

  National Marrow Donor Program, Astellas Pharma Global Development, Inc.

  4/12/18 → 4/12/24

  Project: Research project

• Fundamental Principals of Phase Transformations, Strength and Toughness in High-Strength 10 wt.% Ni Steels for US Naval Applications

  Isheim, D. & Seidman, D. N.

  Office of Naval Research

  4/13/21 → 4/12/24

  Project: Research project

• Prot# V-CA-001: Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO™ Venous Stent System (VIVID)

  Desai, K. R.

  Vesper Medical, Inc.

  4/13/21 → 4/13/24

  Project: Research project

• Super Elongation Complex Disruptors for Cancer Therapeutics

  Shilatifard, A.

  Lakeside Discovery, LLC

  4/15/19 → 4/14/24

  Project: Research project

• Subproject for Institution # SP0064488 Composing Teams with TEAMSTaR: Tool for Evaluating And Mitigating Space Team Risk

  Lungeanu, A. I.

  NASA Lyndon B. Johnson Space Center

  4/15/21 → 4/14/24

  Project: Research project

• Prot #AFT-47: ARACOG: A Randomized Phase II Study of Androgen Receptor Directed Therapy on COGnitive Function in Patients Treated with Darolutamide or Enzalutamide

  VanderWeele, D. J.

  Alliance Foundation Trials, LLC, Bayer Consumer Care AG

  4/14/21 → 4/14/24

  Project: Research project

• DeChurch Subproject Composing Teams with TEAMSTaR: Tool for Evaluating And Mitigating Space Team Risk

  DeChurch, L. A.

  NASA Lyndon B. Johnson Space Center

  4/15/21 → 4/14/24

  Project: Research project

• Blood-Based DNA Methylation Biomarkers of Acquired Platinum Resistance in Women with Ovarian Cancer

  Matei, D. E., Kocherginsky, M. & Cardenas, H.

  Indiana University, U.S. Army Medical Research and Materiel Command

  4/15/21 → 4/14/24

  Project: Research project

• Recombinant annexin A6 to treat muscle disease and muscle injury

  McNally, E. M. & Demonbreun, A. R.

  Lakeside Discovery, LLC

  4/15/19 → 4/14/24

  Project: Research project

• Composing Teams with TEAMSTaR: Tool for Evaluating And Mitigating Space Team Risk

  Contractor, N.

  NASA Lyndon B. Johnson Space Center

  4/15/21 → 4/14/24

  Project: Research project

• Approaches to Integrated Photochemical Systems for Solar Energy Conversion

  Wasielewski, M. R.

  Department of Energy

  4/15/03 → 4/14/24

  Project: Research project

• Prot# BDPI-19-008: A Retrospective, Multi-Center, Real-World Study Assessing the Clinical Use of BARD Long-Term Hemodialysis Catheters

  Desai, K. R.

  Bard Peripheral Vascular, Inc.

  4/15/21 → 4/15/24

  Project: Research project

• Prot #JCAR017-BCM-002: An Exploratory Phase 1/2 Trial to Evaluate the Safety and Efficacy of JCAR017 Combinations in Subjects with Relapsed/Refractory B-Cell Malignancies (PLATFORM)

  Karmali, R.

  Celgene Corporation, Juno Therapeutics, Inc.

  4/17/18 → 4/17/24

  Project: Research project

• Prot #KN035SAR201: ENVASARC: A Pivotal Trial of Envafolimab, and Envafolimab in Combination with Ipilimumab, in Patients with Advanced or Metastatic Undifferentiated Pleomorphic Sarcoma or Myxofibrosarcoma Who Have Progressed on Prior Chemotherapy

  Pollack, S. M.

  TRACON Pharmaceuticals, Inc.

  4/20/21 → 4/20/24

  Project: Research project

• Prot #NU MSK20C04: The PROTECT Study: A Phase II, Open-Label Trial of PROphylactic Skin Toxicity ThErapy with Clindamycin and Triamcinolone in Glioblastoma Patients Treated with Tumor Treating Fields

  Kumthekar, P. U.

  Memorial Sloan-Kettering Cancer Center, Novocure GmbH

  4/20/21 → 4/20/24

  Project: Research project

• Prot #AFT-46: CHIO3 Trial: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

  Patel, J. D.

  Alliance Foundation Trials, LLC, AstraZeneca Pharmaceuticals LP

  4/21/21 → 4/21/24

  Project: Research project

• NMDTI-BMS Strategic Collaboration Agreement

  Giles, F. J.

  Bristol-Myers Squibb Company

  4/23/15 → 4/22/24

  Project: Research project

• Prot #DCC-2618-03-002: A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib

  Kalyan, A.

  Deciphera Pharmaceuticals, LLC

  4/22/19 → 4/22/24

  Project: Research project

• Fellows Subproject for NMDTI-BMS Strategic Collaboration Agreement

  Giles, F. J.

  Bristol-Myers Squibb Company

  4/23/15 → 4/22/24

  Project: Research project

• Prot #ANB019-206: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ANB019 in the Treatment of Subjects with Ichthyosis

  Paller, A.

  Innovaderm Research Inc., AnaptysBio, Inc.

  4/22/21 → 4/22/24

  Project: Research project